Pulmocide
Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory diseases.
25 employees · est. 2013 · London, United Kingdom
Activaero GmbH is the older company (1998 vs 2013); Pulmocide is the larger of the two.
Side-by-Side Comparison
| Metric | Activaero GmbH | Pulmocide |
|---|---|---|
| Founded | ||
| Founded | 1998 older | 2013 |
| Headquarters | ||
| Headquarters | Not tracked yet | London, United Kingdom |
| Employees | ||
| Employees | 3 | 25 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Grant | Series C |
| Total Funding | ||
| Total Funding | $20.83M | $194.90M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Novel Inhaled Medicines, Clinical Development of Opelconazole, Treatment for Invasive Pulmonary Aspergillosis, Research on Aspergillus-related Conditions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Invasive Pulmonary Aspergillosis, Healthcare Providers, Medical Researchers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Respiratory Diseases, Inhaled Therapeutics, Drug Delivery, Pulmonary Delivery, Clinical Development, Controlled Breathing Technologies, Diagnostic Technologies, Contract Development Services, Clinical Trial Logistics, Pharma Partnerships, Biotech Partnerships, Respiratory Therapeutics, Clinical Trials, Smart Card Technology, Flow Limitation Valve | Biopharmaceuticals, Respiratory Diseases, Inhaled Medicines, Fungal Infections, Pulmonary Aspergillosis, Lung Transplant, Drug Development, Inhaled Therapies, Infectious Diseases, Clinical Development, Pharmaceutical Industry |
| Website | ||
| Website | activaero.de | pulmocide.com |
About Activaero GmbH
Activaero GmbH, a biotechnology and healthcare company founded in 1998, focused on developing cutting-edge solutions for severe respiratory diseases such as Asthma, COPD, CF, IPF, and other lung diseases. The company's acquisition by Vectura plc in 2014 added to its credibility. Activaero's propriet...
About Pulmocide
Pulmocide, a biopharmaceutical company founded in 2013 and based in the United Kingdom, is pioneering the development of inhaled medicines for the targeted treatment of life-threatening respiratory diseases. Their core focus is on serious respiratory fungal infections, particularly pulmonary aspergi...
We will tell you when either one moves
BounceWatch watches Activaero GmbH and Pulmocide for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Activaero GmbH and Pulmocide — by email.
Frequently Asked Questions
Compare Activaero GmbH with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Activaero GmbH on 12 Sep 2024, and Pulmocide on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
